Clinical Trial Update: Safety and Tolerability of Dabigatran Etexilate in Adolescents [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety and tolerability of dabigatran etexilate in adolescents with venous thromboembolism; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED | Results posted: 2013-03-26